Natural history of hypertrophic cardiomyopathy: Japanese experience

Y Koga1, T Miyamoto, T Ohtsuki

  • 1Department of Cardiology, Kurume University Medical Center, Kokubumachi 155-1, Kurume, Fukuoka 839-0863, Japan.

Insights

Hypertrophic cardiomyopathy (HCM) is a slowly progressive disease. Over 10 years, patients experienced significant ventricular remodeling, outflow obstruction, and some developed systolic dysfunction.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Medical Science

Background:

  • Hypertrophic cardiomyopathy (HCM) natural history is poorly understood.
  • Some HCM patients progress to severe systolic dysfunction.
  • Understanding HCM progression is crucial for patient management.

Purpose of the Study:

  • To investigate the long-term evolution of hypertrophic cardiomyopathy.
  • To identify changes in ventricular structure and function over time.
  • To understand the progression of left ventricular outflow obstruction and diastolic dysfunction.

Main Methods:

  • Longitudinal follow-up of 59 hypertrophic cardiomyopathy patients for over 10 years.
  • Serial assessment of electrocardiography, ventricular dimensions, and systolic function.
  • Evaluation of left ventricular outflow obstruction and left atrial size.

Main Results:

  • Significant ventricular remodeling observed, including changes in interventricular septum thickness and Q-wave development.
  • Progressive decline in left ventricular systolic function and increased left ventricular end-diastolic diameter in some patients.
  • Evolution of left ventricular outflow obstruction and increased prevalence of atrial fibrillation.

Conclusions:

  • Hypertrophic cardiomyopathy is a slowly progressive condition.
  • HCM involves significant left ventricular remodeling and outflow obstruction.
  • The disease can eventually lead to systolic dysfunction, cavity dilation, and wall thinning.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...